Cempra, Inc. (CEMP): Aisling Capital Slashes Stake as Stock Sinks

Page 2 of 9 SEC Filing

CUSIP No. 15130J 109
SC 13D
Page 2 of 11
1
NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Aisling Capital II, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3
SEC USE ONLY
4
SOURCE OF FUNDS
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
1,232,278
(including 39,218 shares of the Issuer’s common stock issuable upon the exercise
of preferred share purchase warrants expiring on August 5, 2018 (the “Warrants”))
8
SHARED VOTING POWER
0
9
SOLE DISPOSITIVE POWER
1,232,278
10
SHARED DISPOSITIVE POWER
0
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,232,278
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
2.6%(1)
14
TYPE OF REPORTING PERSON
PN

(1)
Based on 48,169,733 shares of the Issuer’s common stock issued and outstanding as of February 18, 2016, as reported in the Issuer’s annual report on Form 10-K filed with the Securities Exchange Commission (the “SEC”) on February 25, 2016.

Follow Melinta Therapeutics Inc. W (NASDAQ:MLNT)